Same Indication

Nivolumab vs Trazodone

Nivolumab vs Trazodone: Overview

This comparison examines the pharmacological differences between Nivolumab and Trazodone.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Trazodone: Serotonin antagonist and reuptake inhibitor (SARI).

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Trazodone β€” 5-9 hours.

Chemical Properties

Molecular Formula: Trazodone β€” C19H22ClN5O.

Molecular Weight: Trazodone β€” 371.8640 g/mol.

Type: Nivolumab β€” Antibody; Trazodone β€” Small molecule.